Live feed20:18:10·100dINSIDERFilingvia QuantisnowEVP, Chief Scientific Officer Bennett C Frank converted options into 21,055 shares and sold $674,622 worth of shares (8,977 units at $75.15), increasing direct ownership by 15% to 94,757 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.IONS· Ionis Pharmaceuticals Inc.Health CareOriginal source
